CVS Health Corporation logo

CVS Health Corporation (CVS)

Market Closed
19 Oct, 08:00 PM
NYSE NYSE
$
92. 68
+0.32
+0.3465%
$
118.13B Market Cap
11.4 P/E Ratio
0.64% Div Yield
5.31M Volume
7.87 Eps
$ 92.36
Previous Close
Add Transaction
Day Range
91.03 92.73
Year Range
69.51 110.68
Want to track CVS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
IMPORTANT ACTION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against CVS Health Corporation and Encourages Investors to Contact the Firm

IMPORTANT ACTION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against CVS Health Corporation and Encourages Investors to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / June 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corporation ("CVS" or "the Company") (NYSE:CVS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 2 years ago
IMPORTANT ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CVS Health Corporation and Encourages Investors to Contact the Firm

IMPORTANT ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against CVS Health Corporation and Encourages Investors to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corporation ("CVS" or "the Company") (NYSE:CVS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 2 years ago
Why Is CVS Health (CVS) Up 1.6% Since Last Earnings Report?

Why Is CVS Health (CVS) Up 1.6% Since Last Earnings Report?

CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?

Zacks | 2 years ago
The S&P 500 Is at Record Levels but These 3 Stocks Are Still Near Their 52-Week Lows

The S&P 500 Is at Record Levels but These 3 Stocks Are Still Near Their 52-Week Lows

Starbucks stock has been struggling as consumer demand continues to stall. Nike's brand remains popular with teens, but sales have underwhelmed of late.

Fool | 2 years ago
Is Trending Stock CVS Health Corporation (CVS) a Buy Now?

Is Trending Stock CVS Health Corporation (CVS) a Buy Now?

CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 2 years ago
CVS: Shares Decimated, But I'm Buying For The 4.6% Yield And Rebound Potential

CVS: Shares Decimated, But I'm Buying For The 4.6% Yield And Rebound Potential

CVS stock has plunged after reporting Q1 2024 results, presenting a potential buying opportunity due to its undervaluation. This stock now offers a 4.63% yield and CVS has built a unique ecosystem that makes it an attractive investment. Medicare Advantage presents a headwind for insurance companies in 2024, but this is a buying opportunity because it offers long-term growth potential.

Seekingalpha | 2 years ago
IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against CVS Health Corporation and Encourages Investors to Contact the Firm

IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against CVS Health Corporation and Encourages Investors to Contact the Firm

LOS ANGELES, CA / ACCESSWIRE / May 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of CVS Health Corporation ("CVS" or "the Company") (NYSE:CVS) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

Accesswire | 2 years ago
CVS Health Corporation (CVS) Bernstein's 40th Annual Strategic Decisions Conference

CVS Health Corporation (CVS) Bernstein's 40th Annual Strategic Decisions Conference

CVS Health Corporation (NYSE:CVS ) Bernstein's 40th Annual Strategic Decisions Conference May 29, 2024 10:00 AM ET Company Participants Karen Lynch - President and CEO Tom Cowhey - Executive Vice President and Chief Financial Officer Conference Call Participants Lance Wilkes - Bernstein Lance Wilkes Okay. So we're going to kick-off.

Seekingalpha | 2 years ago
How Are CVS Health's Profit Margins Trending?

How Are CVS Health's Profit Margins Trending?

CVS Health (NYSE: CVS) saw its net income expand by $4.2 billion or 101% y-o-y to $8.3 billion in 2023. This can primarily be attributed to the opioid litigation charges included in the 2022 results.

Forbes | 2 years ago
2 Beaten-Down Dividend Stocks to Buy and Hold For 10 Years

2 Beaten-Down Dividend Stocks to Buy and Hold For 10 Years

CVS Health provides a comprehensive suite of interrelated healthcare services. Gilead Sciences' sales are growing steadily, and newer approvals should help.

Fool | 2 years ago
CVS Health: Downside Movement Is Overdramatic

CVS Health: Downside Movement Is Overdramatic

CVS Health Corp's share price has fallen, presenting an attractive entry opportunity with a current dividend yield of 4.8%. The risk profile includes slashed guidance and increased costs, but these issues are not unique to CVS and may be temporary. CVS has shown consistent dividend growth over time and has a potential upside of 28.5% based on average Wall St. price targets.

Seekingalpha | 2 years ago
Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in CVS Stock.

Want $1,000 in Dividend Income? Here's How Much You'd Have to Invest in CVS Stock.

CVS has long been a reliable dividend payer. Despite management's recent guidance cut, it still has room to raise its dividend.

Fool | 2 years ago
Loading...
Load More